Nonlinear relationship between body mass index and clinical outcomes after kidney transplantation: A dose-response meta-analysis of 50 observational studies

被引:4
|
作者
Yin, Saifu [1 ]
Wu, Linyan [2 ]
Huang, Zhongli [1 ]
Fan, Yu [1 ]
Lin, Tao [1 ]
Song, Turun [1 ]
机构
[1] Sichuan Univ, West China Hosp, Organ Transplantat Ctr, Urol Res Inst,Urol Dept, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Intens Care Unit, Chengdu, Sichuan, Peoples R China
关键词
PRETRANSPLANT WEIGHT-LOSS; RENAL-TRANSPLANTATION; MORBID-OBESITY; RISK-FACTORS; DIABETES-MELLITUS; RECIPIENT OBESITY; PATIENT SURVIVAL; GRAFT FAILURE; UROLOGIC COMPLICATIONS; ALLOGRAFT FUNCTION;
D O I
10.1016/j.surg.2021.10.024
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Exact dose-response relationship between body mass index at transplantation and clinical outcomes after kidney transplantation remained unclear, and no specific body mass index threshold and pretransplant weight loss aim were recommended for kidney transplantation candidates among transplant centers. Methods: PubMed, Embase, Web of Science, and Cochrane Library were searched for literature published up to December 31, 2019. The two-stage, random effect meta-analysis was performed to estimate the dose-response relationship between body mass index and clinical outcomes after kidney transplantation. Results: Ninety-four studies were included for qualitative assessment and 50 for dose-response metaanalyses. There was a U-shaped relationship between graft loss, patient death, and body mass index. Body mass index with the lowest risk of graft loss was 25.2 kg/m(2), and preferred body mass index range was 22-28 kg/m(2). Referring to a body mass index of 22 kg/m(2), the risk of graft loss was 1.088, 0.981, 1.003, and 1.685 for a body mass index of 18, 24, 28, and 40 kg/m(2), respectively. Body mass index with the lowest risk of patient death was 24.7 kg/m(2), and preferred body mass index range was 22-27 kg/m(2). Referring to a body mass index of 22 kg/m(2), the patient death risk was 1.115, 0.981, 1.032, and 2.634 for a body mass index of 18, 24, 28, and 40 kg/m(2), respectively. J-shaped relationships were observed between body mass index and acute rejection, delayed graft function, primary graft nonfunction, and de novo diabetes. Pair-wise comparisons showed that higher body mass index was also a risk factor for cardiovascular diseases, hypertension, infection, longer length of hospital stay, and lower estimated glomerular filtration rate level. Conclusion: Underweight and severe obesity at transplantation are associated with a significantly increased risk of graft loss and patient death. A target body mass index at kidney transplantation is 22-27 kg/m(2). (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:1396 / 1405
页数:10
相关论文
共 50 条
  • [21] Does body mass index correlate with the mortality of prostate cancer? A dose-response meta-analysis of cohort studies
    Jiang, Wubin
    Chen, Baikang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 88 - 96
  • [22] Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies
    Zhao, Limin
    Tian, Xiaoqin
    Duan, Xueyan
    Ye, Yongxiu
    Sun, Min
    Huang, Junfang
    ONCOTARGET, 2017, 8 (20) : 33990 - 34000
  • [23] The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis
    Huang, Huei-Kai
    Bukhari, Khulood
    Peng, Carol Chiung-Hui
    Hung, Duan-Pei
    Shih, Ming-Chieh
    Chang, Rachel Huai-En
    Lin, Shu-Man
    Munir, Kashif M.
    Tu, Yu-Kang
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1701 - 1709
  • [24] A meta-analysis of observational studies including dose-response relationship between long working hours and risk of obesity
    Li, Wenzhen
    Ruan, Wenyu
    Chen, Zhenlong
    Yi, Guilin
    Lu, Zuxun
    Wang, Dongming
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (04): : 837 - 845
  • [25] Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis
    Liu, Kang
    Zhang, Weining
    Dai, Zhiming
    Wang, Meng
    Tian, Tian
    Liu, Xinghan
    Kang, Huafeng
    Guan, Haitao
    Zhang, Shuqun
    Dai, Zhijun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 143 - 150
  • [26] Response to 'Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis'
    Liu, Yang
    Barnabe, Cheryl
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [27] Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis
    Duan, Peng
    Hu, Chunhui
    Quan, Chao
    Yi, Xianfu
    Zhou, Wei
    Yuan, Meng
    Yu, Tingting
    Kourouma, Ansoumane
    Yang, Kedi
    SCIENTIFIC REPORTS, 2015, 5
  • [28] Body mass index and mortality in chronic obstructive pulmonary disease A dose-response meta-analysis
    Guo, Yibin
    Zhang, Tianyi
    Wang, Zhiyong
    Yu, Feifei
    Xu, Qin
    Guo, Wei
    Wu, Cheng
    He, Jia
    MEDICINE, 2016, 95 (28)
  • [29] Association of Maternal Body Mass Index With Risk of Infant Mortality: A Dose-Response Meta-Analysis
    Huo, Nana
    Zhang, Kun
    Wang, Li
    Wang, Lina
    Lv, Wenhui
    Cheng, Wenke
    Jia, GuangZhu
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [30] Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis
    Peng Duan
    Chunhui Hu
    Chao Quan
    Xianfu Yi
    Wei Zhou
    Meng Yuan
    Tingting Yu
    Ansoumane Kourouma
    Kedi Yang
    Scientific Reports, 5